Search Results 441-450 of 23977 for prostate cancer
... Prostate Cancer. Curr Oncol. 2025 Apr 2; 32 (4) Epub 2025 Apr 02. View PubMed; Gao RW, Ma J, Pisansky TM, Kruse JJ, Stish BJ, Kowalchuk RO, McMenomy BP ...
However, cancer is just one of several possible causes of increased prostate-specific antigen levels. After any procedure for an enlarged prostate, a number of ...
The purpose of this study is to employ mixed methods approach to develop a prostate cancer survivorship care plan (CaP-SCP) tailored to US-born Black men (USbBM) ...
Also, we will evaluate whether the peripheral blood immune cell function is different in B/AA prostate cancer patients with metastatic disease as compared with ...
The purpose of this study is to compare the effects (good and bad) on patients with prostate cancer by comparing the standard dose of radiation therapy (44 ...
About this study. A Phase 2, 2 part trial to evaluate the safety and efficacy of galeterone in castration resistant prostate cancer (CRPC) patients.
... prostate, seminal vesicles, and the regional pelvic nodes for patients who have clinically localized, high risk or unfavorable intermediate risk prostate cancer ...
Apalutamide may help fight prostate cancer by blocking the use of androgen by the tumor cells. Radiation therapy uses high energy rays to kill tumor cells and ...
prostate cancer patient Doug Walsh in a kilt with family and a bagpiper. Doug Walsh came to Mayo Clinic for prostate cancer treatment and decided that while ...
Stage 4 prostate cancer begins in the prostate and grows to nearby organs or spreads to other areas of the body. Learn the symptoms, treatments and ways to cope ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.